2013
DOI: 10.2147/dnnd.s34160
|View full text |Cite
|
Sign up to set email alerts
|

The epidemiology and pathophysiology of pseudobulbar affect and its association with neurodegeneration

Abstract: Pseudobulbar affect is a disorder resulting from neurologic damage manifesting as sudden, stereotyped affective outbursts that are not reflective of internal emotion. A literature review was completed to examine the current understanding of the epidemiology, characterization, diagnosis, pathophysiology, and treatment of pseudobulbar affect. This review revealed that it is common in neurodegenerative disorders but is poorly recognized, placing significant impacts on patients and their families. The disorder app… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
9
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 152 publications
(217 reference statements)
0
9
0
Order By: Relevance
“…Patients with frontotemporal lobar degeneration, which holds pathological overlap with ALS, have also been associated with high levels of pathological laughter ( 43 ), suggesting a shared pathological substrate that would be of interest in future comparative clinical imaging studies. Pharmaceutical agents modulating serotonin/dopamine deficiency, glutamate excess, and sigma type 1 receptor dysfunction have shown varying degrees of efficacy in reducing frequency of PLC episodes ( 1 , 44 ). Future investigation of brainstem-derived neurochemical profiles may help drive therapeutic advances of more efficacious treatment options for managing PLC in ALS patients.…”
Section: Discussionmentioning
confidence: 99%
“…Patients with frontotemporal lobar degeneration, which holds pathological overlap with ALS, have also been associated with high levels of pathological laughter ( 43 ), suggesting a shared pathological substrate that would be of interest in future comparative clinical imaging studies. Pharmaceutical agents modulating serotonin/dopamine deficiency, glutamate excess, and sigma type 1 receptor dysfunction have shown varying degrees of efficacy in reducing frequency of PLC episodes ( 1 , 44 ). Future investigation of brainstem-derived neurochemical profiles may help drive therapeutic advances of more efficacious treatment options for managing PLC in ALS patients.…”
Section: Discussionmentioning
confidence: 99%
“…The patient was thus treated empirically for VAN by an intensification of PD, which proved beneficial. Since the patient was recently prescribed a new medication, and no other etiology was found to have caused the patient's emotional lability, it is presumed that the valacyclovir likely caused neurotoxicity, resulting in the patient's unique emotional lability, and the improvement via PD, which has been reported relatively infrequently [5,6,14].…”
Section: Discussionmentioning
confidence: 99%
“…In ALS-associated PLC, functional and structural neuroimaging studies also supported the role of subcortico-thalamo-ponto-cerebellar network pathways in its pathophysiology, and no correlation with sensory deafferentation. 2,27,[40][41][42][43] Volitional facial movements are generally preserved in patients with emotional facial paresis, due to distinct excitatory pathways from the frontal and temporal cortices and hypothalamus to the periaqueductal gray matter and inhibitory modulation pathways from the lateral premotor cortices areas. 39 Similar pathway dysfunction has been observed in ALS patients secondary to the reduction or lack of inhibitory circuits originating from the frontal cortex due to progressive loss of neurons from the cortical areas ("top-down theory").…”
Section: Are There Different Classifications For the Dlc?mentioning
confidence: 99%